77.63
  Price4.16%   +3.10
(After Hours: 77.65 +0.0200 +0.03%)
Jun-07-22 12:46PM Here's Why These 14 Companies Did A Stock Split In 2022Benzinga
Jun-03-22 07:25AM Is It Time to Buy the S&P 500's 3 Worst-Performing May Stocks?The Motley Fool
Jun-02-22 04:15AM Markets Rise Amid Strength In Tech, SoftwareBenzinga
11:24AM DexCom (DXCM) to Boost Diabetes Management With New CoverageZacks Investment Research
Jun-02-22 10:15AM 2 of the Nasdaq's Best Long-Term Buys Right NowThe Motley Fool
May-31-22 11:12AM Why DexCom Stock Is Jumping TodayThe Motley Fool
May-29-22 01:36AM Avoiding DexCom's 40% Crash In One MonthInvesting.com
May-28-22 06:53AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
May-24-22 04:29AM Norwegian Cruise Line And Caesars Entertainment Lead The S&P 500 Lower: Today's Winners And LosersBenzinga
12:56PM Why DexCom Is Down More Than 11% on TuesdayThe Motley Fool
May-24-22 11:32AM Today’s biggest stock market losers aren’t limited to technology, as economic fears mountMarketWatch
May-19-22 10:17AM Here's Why You Should Hold on to DexCom (DXCM) Stock NowZacks Investment Research
08:44AM Are Options Traders Betting on a Big Move in DexCom (DXCM) Stock?Zacks Investment Research
May-18-22 12:51PM The Correction In Biopharmaceutical Stocks Is Likely OverSeeking Alpha
May-17-22 06:25AM 15 stocks that have fallen at least 33% but by these measures are still standouts in their sectorsMarketWatch
May-16-22 10:52AM 15 stocks that have fallen at least 33% but by these measures are still standouts in their sectorsMarketWatch
May-11-22 11:07AM 2 Unstoppable Growth Stocks to Buy in 2022 and BeyondThe Motley Fool
May-07-22 11:30AM What's Next for Abbott Laboratories' Stock?The Motley Fool
May-01-22 08:18AM 3 Surefire Investments You'll Thank Yourself for LaterThe Motley Fool
Apr-29-22 01:56AM Read Here Why Did This Analyst Cut DexCom's Price TargetBenzinga
06:59AM DexCom (DXCM) Q1 Earnings Miss, Revenues Beat EstimatesZacks Investment Research
Apr-29-22 06:45AM Is DexCom Stock a Buy Now?The Motley Fool
04:00AM DexCom (DXCM) Q1 2022 Earnings Call TranscriptThe Motley Fool
Apr-27-22 08:30AM Is a Surprise Coming for DexCom (DXCM) This Earnings Season?Zacks Investment Research
07:13AM MedTech Stocks' Apr 28 Earnings Roster: ABMD, SYK & MoreZacks Investment Research
Apr-26-22 08:40AM PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?Zacks Investment Research
08:39AM AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?Zacks Investment Research
Apr-25-22 09:47AM What's in Store for West Pharmaceutical's (WST) Q1 Earnings?Zacks Investment Research
09:46AM DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?Zacks Investment Research
Apr-24-22 12:53PM DexCom's Bearish Pattern And Valuation Spell TroubleInvesting.com
Apr-23-22 10:45AM It's Not Too Late to Buy These Market-Beating StocksThe Motley Fool
Apr-22-22 04:09AM Markets Fall Sharply Amid Ongoing Rate Hike ConcernsBenzinga
Apr-21-22 03:01AM DexCom (DXCM) Earnings Expected to Grow: Should You Buy?Zacks Investment Research
09:16AM Baxter (BAX) to Report Q1 Earnings: What's in the Offing?Zacks Investment Research
Apr-19-22 12:45PM Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think " Yes "Zacks Investment Research
11:44AM Merit Medical's (MMSI) Latest Launch to Boost Patient OutcomeZacks Investment Research
Apr-14-22 10:04AM DexCom (DXCM) G6 CGM System Now Available to TRICARE MembersZacks Investment Research
09:50AM Here's Why DexCom (DXCM) is a Strong Momentum StockZacks Investment Research
Apr-11-22 12:16PM Why DexCom Surged 23.6% in MarchThe Motley Fool
Apr-05-22 10:04AM DexCom's (DXCM) Upcoming Launch to Boost Diabetes ManagementZacks Investment Research
Apr-02-22 11:07AM Customers Love These 3 Healthcare CompaniesThe Motley Fool
Mar-29-22 09:05AM DexCom Announces 4-for-1 Stock Split. Here's What Investors Need to Know.The Motley Fool
Mar-28-22 10:54AM Here's Why You Should Hold on to DexCom (DXCM) Stock NowZacks Investment Research
Mar-25-22 04:16AM Markets Have Another Strong Week As S&P 500 Erases Initial Losses From Russia-Ukraine WarBenzinga
Mar-24-22 06:20AM Should iShares Russell MidCap Growth ETF (IWP) Be on Your Investing Radar?Zacks Investment Research
Mar-23-22 10:45AM Is DexCom a Buy?The Motley Fool
Mar-18-22 10:00AM Masimo's (MASI) New Product Expansion to Boost Patient OutcomeZacks Investment Research
Mar-16-22 07:36AM 2 Growth Stocks With More Upside Than Shiba InuThe Motley Fool
Mar-15-22 10:56AM DexCom (DXCM) to Boost Diabetes Management With New ApprovalZacks Investment Research
Mar-14-22 04:41AM Markets Fall In Anticipation Of This Week's Fed DecisionBenzinga
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):